Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-guided dosing of DDAVP and VWF concentrates in von Willebrand disease
NL-OMON54546Recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label trial of desmopressin in von Willebrand disease (VWD) (4 cohorts), sponsored by Erasmus MC. Primary endpoints: Predictive performance in DDAVP testing, Predictive performance in elective procedures and 2 more. Started Oct 2018; status: recruiting.
02
Drugs
desmopressin
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NL-OMON54546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54546.